Access cutting-edge kidney transplant rejection treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access kidney transplant rejection specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related kidney transplant rejection treatment provided free
The purpose of this study is to see: 1. If using these two drugs (carfilzomib and belatacept) together is safe 2. If the use of these two study drugs in addition to the usual immunosuppression for kidney transplant patients can improve your transplanted kidney function by lowering the antibodies you have against your transplanted kidney 3. If the study drugs effect the immune cells that were responding to your donor kidney. And, whether blood or urine tests can measure signs of inflammation and
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Check if you qualify for this kidney transplant rejection clinical trial in Birmingham, AL
If you're searching for kidney transplant rejection treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney transplant rejection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.